(3-hydroxy-3-methylcyclobutyl)-[7-[[6-methyl-3-(trifluoromethyl)-2-pyridinyl]oxy]-2-azaspiro[3.5]nonan-2-yl]methanone
C21H27F3N2O3 — CID 164710268
Data last refreshed: (MolForge compound catalog, from PubChem)
About (3-hydroxy-3-methylcyclobutyl)-[7-[[6-methyl-3-(trifluoromethyl)-2-pyridinyl]oxy]-2-azaspiro[3.5]nonan-2-yl]methanone
(3-hydroxy-3-methylcyclobutyl)-[7-[[6-methyl-3-(trifluoromethyl)-2-pyridinyl]oxy]-2-azaspiro[3.5]nonan-2-yl]methanone (PubChem CID 164710268) has the molecular formula C21H27F3N2O3 and a molecular weight of 412.45 g/mol. Its IUPAC name is (3-hydroxy-3-methylcyclobutyl)-[7-[[6-methyl-3-(trifluoromethyl)-2-pyridinyl]oxy]-2-azaspiro[3.5]nonan-2-yl]methanone.
Molecular Properties
| Compound Name | (3-hydroxy-3-methylcyclobutyl)-[7-[[6-methyl-3-(trifluoromethyl)-2-pyridinyl]oxy]-2-azaspiro[3.5]nonan-2-yl]methanone |
|---|---|
| PubChem CID | 164710268 |
| Molecular Formula | C21H27F3N2O3 |
| Molecular Weight | 412.45 g/mol |
| Exact Mass | 412.20 |
| IUPAC Name | (3-hydroxy-3-methylcyclobutyl)-[7-[[6-methyl-3-(trifluoromethyl)-2-pyridinyl]oxy]-2-azaspiro[3.5]nonan-2-yl]methanone |
| SMILES | Cc1ccc(C(F)(F)F)c(OC2CCC3(CC2)CN(C(=O)C2CC(C)(O)C2)C3)n1 |
| InChI | InChI=1S/C21H27F3N2O3/c1-13-3-4-16(21(22,23)24)17(25-13)29-15-5-7-20(8-6-15)11-26(12-20)18(27)14-9-19(2,28)10-14/h3-4,14-15,28H,5-12H2,1-2H3 |
| InChIKey | FLYKQSLQHCCTKH-UHFFFAOYSA-N |
| XLogP | 3.72 |
| TPSA | 62.66 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 4 |
| Rotatable Bonds | 3 |
| Heavy Atoms | 29 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 412.45 |
| LogP ≤ 5 | 3.72 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 4 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 164710268 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.